Literature DB >> 24910023

Clinical association between non-alcoholic fatty liver disease and the development of hypertension.

Jae-Hong Ryoo1, Young Ju Suh, Ho Cheol Shin, Yong Kyun Cho, Joong-Myung Choi, Sung Keun Park.   

Abstract

BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) is getting an increasing attention for its clinical implications on cardiovascular disease (CVD). However, epidemiologic data are not so evident to sustain the causative association between NAFLD and hypertension, the major cause of CVD. Accordingly, we designed this study to investigate the clinical association between NAFLD and the development of hypertension.
METHODS: To assess the natural course of blood pressure according to degree of NAFLD (normal, mild, and moderate to severe), we conducted a prospective cohort study on the 22 090 Korean men without hypertension for 5 years. We serially checked the various metabolic factors including systolic and diastolic blood pressure in order to monitor the development of hypertension.
RESULTS: The incidence rate of hypertension increased according to the degree of NAFLD (normal: 14.4%, mild: 21.8%, moderate to severe: 30.1%, P < 0.001). Even after adjusting for other multiple covariates, the hazard ratios (95% confidence intervals) for hypertension were higher in the mild group (1.07; 1.00-1.15) and moderate to severe group (1.14; 1.00-1.30), compared with normal group, respectively (P for trend < 0.001).
CONCLUSION: Development of hypertension is more potentially associated with the more progressive NAFLD than normal or milder state. In addition, NAFLD was an independent risk factor for hypertension.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  cardiovascular disease; hypertension; non-alcoholic fatty liver disease

Mesh:

Year:  2014        PMID: 24910023     DOI: 10.1111/jgh.12643

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  31 in total

1.  Association between nonalcoholic fatty liver disease and colorectal adenoma: a systematic review and meta-analysis.

Authors:  Wenjin Ding; Jiangao Fan; Jianjun Qin
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.

Authors:  Ren-Nan Feng; Shan-Shan Du; Cheng Wang; Yan-Chuan Li; Li-Yan Liu; Fu-Chuan Guo; Chang-Hao Sun
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

3.  Bi-directional analysis between fatty liver and cardiovascular disease risk factors.

Authors:  Jiantao Ma; Shih-Jen Hwang; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Raymond T Chung; Emelia J Benjamin; Daniel Levy; Caroline S Fox; Michelle T Long
Journal:  J Hepatol       Date:  2016-10-10       Impact factor: 25.083

4.  Palm tocotrienol rich fraction with palm kernel oil supplementation prevents development of liver steatosis in high fat diet ICR mice.

Authors:  Mohd Danial Mohd Efendy Goon; Nur Izzati Zulkanain; Siti Hamimah Sheikh Abdul Kadir; Sharaniza Ab Rahim; Musalmah Mazlan; Normala Abd Latip; Mardiana Abdul Aziz; Norizal Mohd Noor
Journal:  Transl Gastroenterol Hepatol       Date:  2022-01-25

Review 5.  Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease.

Authors:  Gashaw Hassen; Abhishek Singh; Gizeshwork Belete; Nidhi Jain; Ivonne De la Hoz; Genesis P Camacho-Leon; Nitsuh K Dargie; Keila G Carrera; Tadesse Alemu; Sharan Jhaveri; Nebiyou Solomon
Journal:  Cureus       Date:  2022-05-30

Review 6.  Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease.

Authors:  Nicholas W S Chew; Cheng Han Ng; Mark Dhinesh Muthiah; Arun J Sanyal
Journal:  Curr Atheroscler Rep       Date:  2022-05-04       Impact factor: 5.967

Review 7.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

8.  Association between non-alcoholic hepatic steatosis and hyper reactive blood pressure response on the exercise treadmill test.

Authors:  A G Laurinavicius; M S Bittencourt; M J Blaha; F C Nary; N M Kashiwagi; R D Conceiçao; R S Meneghelo; R R Prado; J A M Carvalho; K Nasir; R S Blumenthal; R D Santos
Journal:  QJM       Date:  2016-01-19

Review 9.  NAFLD and cardiovascular diseases: a clinical review.

Authors:  Philipp Kasper; Anna Martin; Sonja Lang; Fabian Kütting; Tobias Goeser; Münevver Demir; Hans-Michael Steffen
Journal:  Clin Res Cardiol       Date:  2020-07-21       Impact factor: 5.460

Review 10.  Comorbidities and Metabolic Derangement of NAFLD.

Authors:  Ki Bae Bang; Yong Kyun Cho
Journal:  J Lifestyle Med       Date:  2015-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.